Cullen/Frost Bankers’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Cullen/Frost Bankers’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.12K	Buy	+26	New	+$3.52K	﹤0.01%	1233
2021 Q1	–	Sell	-10	Closed	-$1K	–	1149
2020 Q4	$1K	Hold	10	–	–	﹤0.01%	1050
2020 Q3	$1K	Buy	+10	New	+$1.12K	﹤0.01%	1133
2020 Q1	–	Sell	-291	Closed	-$28K	–	1043
2019 Q4	$28K	Buy	291 +239	+460%	+$20.7K	﹤0.01%	728
2019 Q3	$4K	Buy	+52	New	+$4.32K	﹤0.01%	937

Other funds holding XBI

PSP Research Newtown Square, Pennsylvania $188M AUM

Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

WAM

Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return

RFM

Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return

NHFG

New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return

RAM

Riggs Asset Management Dallas, Pennsylvania $560M AUM 64.94% 1-Year Est. Return

MFS

Madrona Financial Services Everett, Washington $543M AUM 30.87% 1-Year Est. Return

LRPA

L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return

WTC

WhitTier Trust Company Reno, Nevada $5.35B AUM 29.91% 1-Year Est. Return

Cullen/Frost Bankers's XBI Position: Q2 2026 in Review

Cullen/Frost Bankers opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 26 shares worth $4.12K. The stake represents ﹤0.01% of the portfolio and ranks #1233 among its holdings. This is a return to the name: Cullen/Frost Bankers previously reported a position in XBI as recently as Q4 2020.

Cullen/Frost Bankers first reported a position in XBI in Q3 2019 and has held it in 5 quarters since. The position peaked at $28K in Q4 2019. 342 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Cullen/Frost Bankers held 26 shares of State Street SPDR S&P Biotech ETF worth $4.12K as of Q2 2026.
State Street SPDR S&P Biotech ETF was a new Cullen/Frost Bankers position in Q2 2026.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Cullen/Frost Bankers's portfolio in Q2 2026, its #1233 holding.
Cullen/Frost Bankers first reported a position in State Street SPDR S&P Biotech ETF in Q3 2019 and has held it in 5 quarters since.
Cullen/Frost Bankers's State Street SPDR S&P Biotech ETF position peaked at $28K in Q4 2019.
342 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.